Quotient Limited (QTNT) Fundamentals

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.
SHARE INFORMATION
Market Cap$ 22,570,326
Shares Outstanding135,802,201
Float68,695,413
Percent Float50.58%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 38,514,000
Latest Fiscal EPS$ -1.24
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions216
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months12,652,896
Institutional Holdings Percent95.3%
Institutional Sold Previous 3 Months19,145,366
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months10,510,718
Insider Holdings Percent2.9
Insider Sold Previous 3 Months74,989
Insider Shares Owned3,981,996
TRADING INFO
52 Week High$ 3.19
52 Week Low$ 0.14
52 Week High Change$ -94.29
21 Day Moving Average$ 0.1755
21 Day Extended Moving Average$ 0.175039
50 Day Moving Average$ 0.207
50 Day Extended Moving Average$ 0.216203
200 Day Moving Average$ 0.823484
200 Day Extended Moving Average$ 0.894332
10 Day Average Volume1,340,522
20 Day Average Volume3,541,745
30 Day Average Volume3,928,366
50 Day Average Volume2,975,066
Alpha-0.040266
Beta2.6889
Standard Deviation0.294715
R20.226318
7 Day Price Change$ 0.0212
7 Day Percent Change14.62%
21 Day Price Change$ -0.0253
21 Day Percent Change-13.21%
30 Day Price Change$ -0.0082
30 Day Percent Change-4.7%
Month to Date Price Change$ 0.0162
Month to Date Percent Change10.8%
Quarter to Date Price Change$ 0.0162
Quarter to Date Percent Change10.8%
180 Day Price Change$ -1.03
180 Day Percent Change-86.15%
200 Day Price Change$ -0.8638
200 Day Percent Change-83.86%
Year to Date Price Change$ -2.42
Year to Date Percent Change-93.58%

Quotient Limited (QTNT) Key Ratios

PROFITABILITY
EBIT Margin-258.3%
EBITDA Margin-240.1%
Pre-Tax Profit Margin-364.9%
Profit Margin Count0.0%
Gross Margin34.5%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 28,772,000
Revenue Per Share$ 0.2119
Revenue (3 Years)$ -4.08
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.10
Total Debt To Equity24.20
Int Coverage-2.60
Current Ratio3.00
Leverage Ratio-1.20
Quick Ratio1.90
Long Term Debt To Capital0.95
VALUATION MEASURES
PE Ratio-0.10
Enterprise Value$ 240,220,367
Price to Sales0.784455
Price to Free Cash-0.20
PE High Last 5 Years-2.60
Price To Book58.40
Price To Cash Flow0.00
PE Low Last 5 Years-2.40
Price to Tangible Book-0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.80
Invoice Turnover1.10
Assets Turnover0.20
Return Assets-65.26
Return on Equity138.96
Return on Capital-39.96

Quotient Limited (QTNT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOManuel O. Mendez Muniz
Emplyoees437
Last AuditUE
CIK0001596946
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
AddressBusiness Park Terre Bonne
Route de Crassier 13
Eysins, 1262
Websitehttps://www.quotientbd.com
Facsimile-
Telephone+41 41227169800
Emailchris.lindop@quotientbd.com


Your Recent History
NASDAQ
QTNT
Quotient
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.